Analyst ratings and price targets are significant indicators for investors, often influencing stock prices. The reiteration of a Buy rating and an $8 price target by a reputable analyst like Robert Wasserman from Benchmark could be seen as a strong endorsement of OmniAb's value and potential, likely leading to positive investor sentiment and a potential uplift in the stock's price in the short term.